David Scott Jones, SVP & Chief Commercial Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 209 shares at $28.49 ($6K) on 2024-02-02, disclosed to the SEC on 2024-02-05.
Open-market sale of $6k EYPT by SVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EYPT | SELL | 2024-01-24 | $1.6M | — | Filing → |